301 related articles for article (PubMed ID: 14633684)
41. DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma.
Kim TY; Lee JW; Kim HP; Jong HS; Kim TY; Jung M; Bang YJ
Biochem Biophys Res Commun; 2007 Mar; 355(1):72-7. PubMed ID: 17292327
[TBL] [Abstract][Full Text] [Related]
42. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma.
Sonoda I; Imoto I; Inoue J; Shibata T; Shimada Y; Chin K; Imamura M; Amagasa T; Gray JW; Hirohashi S; Inazawa J
Cancer Res; 2004 Jun; 64(11):3741-7. PubMed ID: 15172977
[TBL] [Abstract][Full Text] [Related]
43. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
[TBL] [Abstract][Full Text] [Related]
44. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
45. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
46. The basal body gene, RPGRIP1L, is a candidate tumour suppressor gene in human hepatocellular carcinoma.
Lin YW; Yan MD; Shih YL; Hsieh CB
Eur J Cancer; 2009 Jul; 45(11):2041-9. PubMed ID: 19410446
[TBL] [Abstract][Full Text] [Related]
47. Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma.
Kim CJ; Song JH; Cho YG; Cao Z; Lee YS; Nam SW; Lee JY; Park WS
Histopathology; 2008 Apr; 52(5):552-9. PubMed ID: 18312352
[TBL] [Abstract][Full Text] [Related]
48. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
[TBL] [Abstract][Full Text] [Related]
49. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.
Liedtke C; Zschemisch NH; Cohrs A; Roskams T; Borlak J; Manns MP; Trautwein C
Gastroenterology; 2005 Nov; 129(5):1602-15. PubMed ID: 16285959
[TBL] [Abstract][Full Text] [Related]
50. The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle.
Qiu GH; Salto-Tellez M; Ross JA; Yeo W; Cui Y; Wheelhouse N; Chen GG; Harrison D; Lai P; Tao Q; Hooi SC
J Hepatol; 2008 Mar; 48(3):433-41. PubMed ID: 18191269
[TBL] [Abstract][Full Text] [Related]
51. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
52. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
[TBL] [Abstract][Full Text] [Related]
53. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma.
Kondo Y; Kanai Y; Sakamoto M; Mizokami M; Ueda R; Hirohashi S
Hepatology; 2000 Nov; 32(5):970-9. PubMed ID: 11050047
[TBL] [Abstract][Full Text] [Related]
54. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
[TBL] [Abstract][Full Text] [Related]
55. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.
Zöchbauer-Müller S; Fong KM; Maitra A; Lam S; Geradts J; Ashfaq R; Virmani AK; Milchgrub S; Gazdar AF; Minna JD
Cancer Res; 2001 May; 61(9):3581-5. PubMed ID: 11325823
[TBL] [Abstract][Full Text] [Related]
56. Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma.
Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U
J Pathol; 2014 Aug; 233(4):392-401. PubMed ID: 24838394
[TBL] [Abstract][Full Text] [Related]
57. Methylation status of genes upregulated by demethylating agent 5-aza-2'-deoxycytidine in hepatocellular carcinoma.
Hirasawa Y; Arai M; Imazeki F; Tada M; Mikata R; Fukai K; Miyazaki M; Ochiai T; Saisho H; Yokosuka O
Oncology; 2006; 71(1-2):77-85. PubMed ID: 17341888
[TBL] [Abstract][Full Text] [Related]
58. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
59. Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms.
Goeppert B; Schmezer P; Dutruel C; Oakes C; Renner M; Breinig M; Warth A; Vogel MN; Mittelbronn M; Mehrabi A; Gdynia G; Penzel R; Longerich T; Breuhahn K; Popanda O; Plass C; Schirmacher P; Kern MA
Hepatology; 2010 Dec; 52(6):2023-33. PubMed ID: 20979053
[TBL] [Abstract][Full Text] [Related]
60. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
